(Feb 9, 2023, Dubai, UAE) From February 6 to 9, 2023, Fapon Biotech Inc. (Fapon Biotech or the Company) attended the Medlab Middle East (Medlab ME) in Dubai, UAE. At the exhibition, Fapon Biotech presented its upgraded product portfolio, including core IVD raw materials, reagent services and open instrument platforms. Above all, the Company introduced and drew attention to its one-stop solutions in both the chemiluminescence and rapid test industry.
With the aim of paving the way for technological advancements and sustainability in laboratory medicine, the 22nd edition of the Medlab ME annual gathering brought together 700+ exhibitors from 40+ countries, showcasing the latest laboratory innovations and technologies. With over two decades of R&D experience and extensive resources from across the globe, Fapon Biotech is now a leading and pivotal company in both the Chinese life sciences industry and the global IVD industry. The Company met with worldwide IVD partners at Medlab ME, showcasing its advancements and latest IVD innovations.
Open Instrument Platforms on Display
Two of Fapon Biotech’s featured instruments were on full display, namely Shine i1000 chemiluminescence immunoassay analyzer and Shine i2000 chemiluminescence immunoassay analyzer. Equipped with Fapon Biotech’s excellent core raw materials and reagent services, the instruments is capable of providing a one-stop solution for chemiluminescence immunoassay. In addition, Fapon Biotech has brought about two new instruments specially designed for molecular diagnostics. One was the FAtraction32 Nucleic Acid Extraction System, which uses magnetic bead separation technology to transfer magnetic beads between deep-well plates containing specific reagents. The other was the FAlight16 Rapid Real-time fluorescent quantitative PCR system, which uses innovative liquid circulation refrigeration combined with unique Peltier temperature control technology to ensure uniform and precise temperature control that is equivalent to the performance of a desktop qPCR analyzer.
Expansive Chemiluminescence Ecosystem Empowers Partners
In accordance with the mission of empowering timely, accurate and affordable diagnosis for all, Fapon Biotech has launched its expansive ecosystem concept for chemiluminescence immunoassay, which empowers partners to transform them from dealers to manufacturers. Fapon Biotech introduced its self-developed series of high-performance chemiluminescence immunoassay analyzers that are open and fully customizable: Shine i1000, the smallest fully automatic chemiluminescence immunoassay analyzer which has three different models of AE, AP and HRP protocols, and Shine i2000, the compact yet robust and large capacity analyzer which has four different models of AE, AP, HRP, ABEI protocols.
With over two decades of experience in the IVD industry, Fapon Biotech has established a comprehensive technology platform and developed a wide range of product lines. It now provides compact, accurate and affordable chemiluminescence analyzers via Fapon’s ecosystem reagent panels. Additionally, technical services such as factory construction design, product registration support, construction of quality assurance system, professional and quick customer services are also available.
Powerful Technical Transfer Empowers Local Rapid Test Industry
After the COVID-19 epidemic, the government has gradually realized the importance of the local development of IVD companies, and many countries have introduced policies to encourage localized production, such as Indonesia, Kenya, Egypt, etc. Considering the huge pressure surrounding cost and fierce market competition for localized production, Fapon Biotech has launched a one-stop rapid test solution to help worldwide local enterprises build their own brands from 0 to 1. From plant construction to equipment purchase, from personnel training to production supply, Fapon Biotech has been providing comprehensive and tailored localized production solutions. Leaning on its thorough understanding of raw materials, the Company has continuously empowered overseas markets and gradually helped partners localize production. Take its Indian market as an example, Fapon Biotech’s underlying technology has empowered many top medical device customers in building diagnostic product lines in India.
Focused on IVD underlying technology and product R&D, Fapon Biotech will continue to harness its global innovation network and contribute to the global IVD industry’s progression and development with more partners.